BioCentury
ARTICLE | Clinical News

Synflorix: Phase III data

December 17, 2012 8:00 AM UTC

The double-blind, Finish Phase III FinIP trial in 47,369 children ages <19 months showed that there were no culture-confirmed vaccine-type cases of invasive pneumococcal disease detected in children r...